Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,966 | 63 | 61.8% |
| Travel and Lodging | $1,833 | 10 | 38.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca UK Limited | $1,930 | 8 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $922.07 | 12 | $0 (2021) |
| GENZYME CORPORATION | $587.47 | 8 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $289.77 | 7 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $279.09 | 11 | $0 (2023) |
| GlaxoSmithKline, LLC. | $184.59 | 5 | $0 (2023) |
| Genentech USA, Inc. | $167.44 | 9 | $0 (2022) |
| ALK-Abello, Inc | $111.26 | 1 | $0 (2019) |
| Amgen Inc. | $106.00 | 1 | $0 (2020) |
| Merck Sharp & Dohme LLC | $64.75 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $116.07 | 1 | GENZYME CORPORATION ($116.07) |
| 2023 | $197.23 | 7 | AstraZeneca Pharmaceuticals LP ($97.26) |
| 2022 | $124.16 | 6 | AstraZeneca Pharmaceuticals LP ($53.53) |
| 2021 | $279.20 | 8 | GENZYME CORPORATION ($142.86) |
| 2020 | $335.77 | 7 | Regeneron Healthcare Solutions, Inc. ($154.68) |
| 2019 | $2,573 | 24 | AstraZeneca UK Limited ($1,930) |
| 2018 | $320.39 | 7 | GlaxoSmithKline, LLC. ($148.96) |
| 2017 | $853.80 | 13 | Novartis Pharmaceuticals Corporation ($715.17) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 2 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/12/2020 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/10/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: Respiratory | ||||||
| 01/21/2020 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Immunology | ||||||
| 01/10/2020 | Amgen Inc. | — | Travel and Lodging | In-kind items and services | $106.00 | General |
| 11/18/2019 | AstraZeneca UK Limited | FASENRA (Drug) | Food and Beverage | In-kind items and services | $238.70 | General |
| Category: Respiratory | ||||||
| 11/18/2019 | AstraZeneca UK Limited | FASENRA (Drug) | Food and Beverage | In-kind items and services | $238.70 | General |
| Category: Respiratory | ||||||
| 11/18/2019 | AstraZeneca UK Limited | FASENRA (Drug) | Travel and Lodging | In-kind items and services | $75.49 | General |
| Category: Respiratory | ||||||
| 11/18/2019 | AstraZeneca UK Limited | FASENRA (Drug) | Food and Beverage | In-kind items and services | $68.20 | General |
| Category: Respiratory | ||||||
| 11/18/2019 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Immunology | ||||||
| 11/17/2019 | AstraZeneca UK Limited | FASENRA (Drug) | Travel and Lodging | In-kind items and services | $604.90 | General |
| Category: Respiratory | ||||||
| 11/17/2019 | AstraZeneca UK Limited | FASENRA (Drug) | Travel and Lodging | In-kind items and services | $320.71 | General |
| Category: Respiratory | ||||||
| 11/17/2019 | AstraZeneca UK Limited | FASENRA (Drug) | Food and Beverage | In-kind items and services | $238.70 | General |
| Category: Respiratory | ||||||
| 11/17/2019 | AstraZeneca UK Limited | FASENRA (Drug) | Travel and Lodging | In-kind items and services | $144.40 | General |
| Category: Respiratory | ||||||
| 11/09/2019 | ALK-Abello, Inc | Odactra (Drug), Ragwitek, Grastek | Food and Beverage | In-kind items and services | $111.26 | General |
| Category: Allergy and Immunology | ||||||
| 11/09/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $43.83 | General |
| Category: Respiratory | ||||||
| 10/28/2019 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: RESPIRATORY | ||||||
| 09/16/2019 | GENZYME CORPORATION | DUPIXENT (Drug) | Food and Beverage | In-kind items and services | $124.55 | General |
| Category: IMMUNOLOGY | ||||||
| 09/09/2019 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Immunology | ||||||
| 08/12/2019 | GENZYME CORPORATION | DUPIXENT (Drug), DUPIXENT | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2019 | Circassia Pharmaceuticals Inc | NIOX VERO (Device) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: ALLERGY AND ASTHMA | ||||||
| 07/16/2019 | GENZYME CORPORATION | DUPIXENT (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: IMMUNOLOGY | ||||||
| 07/15/2019 | Merck Sharp & Dohme Corporation | ASMANEX (Drug), DULERA | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: RESPIRATORY | ||||||
| 06/24/2019 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Immunology | ||||||
| 06/19/2019 | GENZYME CORPORATION | DUPIXENT (Drug) | Food and Beverage | In-kind items and services | $116.36 | General |
| Category: IMMUNOLOGY | ||||||
| 05/13/2019 | Kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: ALLERGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 99 | 755 | $43,780 | $16,389 |
| 2022 | 3 | 59 | 649 | $33,650 | $11,223 |
| 2021 | 7 | 114 | 2,290 | $96,120 | $34,612 |
| 2020 | 8 | 157 | 2,575 | $106,253 | $36,617 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 37 | 37 | $14,800 | $6,931 | 46.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 54 | $13,500 | $6,381 | 47.3% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 13 | 648 | $13,880 | $2,667 | 19.2% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 14 | 16 | $1,600 | $410.24 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 37 | $9,250 | $4,489 | 48.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 22 | 22 | $9,650 | $4,148 | 43.0% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 11 | 590 | $14,750 | $2,586 | 17.5% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 13 | 970 | $34,920 | $15,252 | 43.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 38 | $9,500 | $4,560 | 48.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 21 | 21 | $8,400 | $4,515 | 53.8% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 15 | 892 | $22,300 | $3,982 | 17.9% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 14 | 175 | $10,500 | $3,789 | 36.1% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 13 | 178 | $8,900 | $2,044 | 23.0% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 15 | 16 | $1,600 | $469.44 | 29.3% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2020 | 12 | 996 | $33,861 | $14,266 | 42.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 36 | 69 | $16,832 | $6,750 | 40.1% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2020 | 18 | 1,076 | $20,130 | $4,812 | 23.9% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 12 | 177 | $13,329 | $3,903 | 29.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 24 | 24 | $9,834 | $3,607 | 36.7% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2020 | 12 | 186 | $8,089 | $2,007 | 24.8% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 26 | 29 | $3,367 | $972.23 | 28.9% |
| 94664 | Demonstration and/or evaluation of patient use of aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure breathing (ippb) device | Office | 2020 | 17 | 18 | $811.30 | $301.40 | 37.2% |
About Dr. Bernard Silverman, MD
Dr. Bernard Silverman, MD is a Allergy & Immunology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/25/2005. The National Provider Identifier (NPI) number assigned to this provider is 1033192836.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bernard Silverman, MD has received a total of $4,799 in payments from pharmaceutical and medical device companies, with $116.07 received in 2024. These payments were reported across 73 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($2,966).
As a Medicare-enrolled provider, Silverman has provided services to 429 Medicare beneficiaries, totaling 6,269 services with total Medicare billing of $98,840. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Allergy & Immunology
- Location Brooklyn, NY
- Active Since 11/25/2005
- Last Updated 04/24/2017
- Taxonomy Code 207K00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1033192836
Products in Payments
- FASENRA (Drug) $2,002
- FEVIPIPRANT (Drug) $642.11
- DUPIXENT (Biological) $569.90
- DUPIXENT (Drug) $307.34
- NUCALA (Biological) $184.59
- Xolair (Biological) $167.44
- Odactra (Drug) $111.26
- XOLAIR (Biological) $89.96
- AIRSUPRA (Drug) $70.11
- TEZSPIRE (Biological) $65.58
- Dymista (Drug) $37.10
- ASMANEX (Drug) $35.79
- AirDuo Digihaler (Drug) $31.75
- EUCRISA (Drug) $27.04
- AUVI-Q (Drug) $24.46
- TUDORZA PRESSAIR (Drug) $18.55
- NIOX VERO (Device) $18.23
- FASENRA (Biological) $15.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in Brooklyn
Dr. Payel Gupta, Md, MD
Allergy & Immunology — Payments: $175,492
Richard Kolchin, Md, MD
Allergy & Immunology — Payments: $107,206
Gad Avshalomov, Md, MD
Allergy & Immunology — Payments: $65,693
Dina Liberman, M.d, M.D
Allergy & Immunology — Payments: $41,185
Jenny Shliozberg, M.d, M.D
Allergy & Immunology — Payments: $13,165
Dr. David Sanchez, Md, MD
Allergy & Immunology — Payments: $12,785